APO Research
Talk to an analyst

APO RESEARCH · REPORT

Burosumab

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Burosumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025172 pages

Choose your research edition.

Industry ResearchBurosumab Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Burosumab Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Burosumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Burosumab Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Burosumab Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Burosumab market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Burosumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Burosumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Burosumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Burosumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Burosumab include Ultragenyx and Kyowa Kirin Co.,Ltd. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Burosumab market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Burosumab and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Burosumab sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Burosumab market size, projected growth trends, production technologies, key applications, and end-use industries.

Burosumab Segment by Company

Ultragenyx

Kyowa Kirin Co.,Ltd.

Burosumab Segment by Type

10mg/mL

20mg/mL

30mg/mL

Burosumab Segment by Application

Minor Patients Over 1 Year Old

Adult Patients

Burosumab Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Burosumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Burosumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Burosumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Burosumab market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Burosumab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Burosumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Burosumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Burosumab Industry Trends Table 2. Burosumab Industry Drivers Table 3. Burosumab Industry Opportunities and Challenges Table 4. Burosumab Industry Restraints Table 5. Global Burosumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Burosumab Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Burosumab Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Burosumab Sales Market Share by Manufacturers Table 9. Global Burosumab Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Burosumab Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Burosumab Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Burosumab Manufacturers, Product Type & Application Table 13. Global Burosumab Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Burosumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mg/mL Table 17. Major Manufacturers of 20mg/mL Table 18. Major Manufacturers of 30mg/mL Table 19. Global Burosumab Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Burosumab Sales by Type (2021-2026) & (K Units) Table 21. Global Burosumab Sales by Type (2027-2032) & (K Units) Table 22. Global Burosumab Sales Market Share by Type (2021-2026) Table 23. Global Burosumab Sales Market Share by Type (2027-2032) Table 24. Global Burosumab Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Burosumab Revenue by Type (2021-2026) & (K Units) Table 26. Global Burosumab Revenue by Type (2027-2032) & (K Units) Table 27. Global Burosumab Revenue Market Share by Type (2021-2026) Table 28. Global Burosumab Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Minor Patients Over 1 Year Old Table 30. Major Manufacturers of Adult Patients Table 31. Global Burosumab Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Burosumab Sales by Application (2021-2026) & (K Units) Table 33. Global Burosumab Sales by Application (2027-2032) & (K Units) Table 34. Global Burosumab Sales Market Share by Application (2021-2026) Table 35. Global Burosumab Sales Market Share by Application (2027-2032) Table 36. Global Burosumab Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Burosumab Revenue by Application (2021-2026) & (K Units) Table 38. Global Burosumab Revenue by Application (2027-2032) & (K Units) Table 39. Global Burosumab Revenue Market Share by Application (2021-2026) Table 40. Global Burosumab Revenue Market Share by Application (2027-2032) Table 41. Global Burosumab Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Burosumab Sales by Region (2021-2026) & (K Units) Table 43. Global Burosumab Sales Market Share by Region (2021-2026) Table 44. Global Burosumab Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Burosumab Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Burosumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Burosumab Sales by Country (2021-2026) & (K Units) Table 48. North America Burosumab Sales by Country (2027-2032) & (K Units) Table 49. Europe Burosumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Burosumab Sales by Country (2021-2026) & (K Units) Table 51. Europe Burosumab Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Burosumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Burosumab Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Burosumab Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Burosumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Burosumab Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Burosumab Sales by Country (2027-2032) & (K Units) Table 58. Global Burosumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Burosumab Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Burosumab Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Burosumab Revenue Market Share by Region (2021-2026) Table 62. Global Burosumab Revenue Market Share by Region (2027-2032) Table 63. Ultragenyx Company Information Table 64. Ultragenyx Business Overview Table 65. Ultragenyx Burosumab Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Ultragenyx Burosumab Product Portfolio Table 67. Ultragenyx Recent Development Table 68. Kyowa Kirin Co.,Ltd. Company Information Table 69. Kyowa Kirin Co.,Ltd. Business Overview Table 70. Kyowa Kirin Co.,Ltd. Burosumab Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Kyowa Kirin Co.,Ltd. Burosumab Product Portfolio Table 72. Kyowa Kirin Co.,Ltd. Recent Development Table 73. Key Raw Materials Table 74. Raw Materials Key Suppliers Table 75. Burosumab Distributors List Table 76. Burosumab Customers List Table 77. Research Programs/Design for This Report Table 78. Authors List of This Report Table 79. Secondary Sources Table 80. Primary Sources List of Figures Figure 1. Burosumab Product Image Figure 2. Global Burosumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Burosumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Burosumab Sales (2021-2032) & (K Units) Figure 5. Global Burosumab Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Burosumab Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mg/mL Image Figure 9. 20mg/mL Image Figure 10. 30mg/mL Image Figure 11. Global Burosumab Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Burosumab Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Burosumab Sales Market Share by Type (2021-2032) Figure 14. Global Burosumab Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Burosumab Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Burosumab Revenue Market Share by Type (2021-2032) Figure 17. Minor Patients Over 1 Year Old Image Figure 18. Adult Patients Image Figure 19. Global Burosumab Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Burosumab Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Burosumab Sales Market Share by Application (2021-2032) Figure 22. Global Burosumab Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Burosumab Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Burosumab Revenue Market Share by Application (2021-2032) Figure 25. North America Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Burosumab Sales Market Share by Country (2021-2032) Figure 27. U.S. Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Burosumab Sales Market Share by Country (2021-2032) Figure 32. Germany Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Burosumab Sales Market Share by Country (2021-2032) Figure 39. China Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Burosumab Sales Market Share by Country (2021-2032) Figure 47. Brazil Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Burosumab Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Burosumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Burosumab Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Burosumab Revenue (2021-2032) & (US$ Million) Figure 58. North America Burosumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Burosumab Revenue (2021-2032) & (US$ Million) Figure 60. Europe Burosumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Burosumab Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Burosumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Burosumab Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Burosumab Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Burosumab Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Burosumab Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/mL
  • 20mg/mL
  • 30mg/mL
Applications
  • Minor Patients Over 1 Year Old
  • Adult Patients
Companies covered
  • Ultragenyx
  • Kyowa Kirin Co.,Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Burosumab Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Burosumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Burosumab Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Burosumab Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Burosumab Market Dynamics
  1. 2.1 Burosumab Industry Trends
  2. 2.2 Burosumab Industry Drivers
  3. 2.3 Burosumab Industry Opportunities and Challenges
  4. 2.4 Burosumab Industry Restraints
3 Burosumab Market by Manufacturers
  1. 3.1 Global Burosumab Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Burosumab Sales by Manufacturers (2021-2026)
  3. 3.3 Global Burosumab Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Burosumab Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Burosumab Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Burosumab Manufacturers, Product Type & Application
  7. 3.7 Global Burosumab Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Burosumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Burosumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Burosumab Tier 1, Tier 2, and Tier 3
4 Burosumab Market by Type
  1. 4.1 Burosumab Type Introduction
  2. 4.1.1 10mg/mL
  3. 4.1.2 20mg/mL
  4. 4.1.3 30mg/mL
  5. 4.2 Global Burosumab Sales by Type
  6. 4.2.1 Global Burosumab Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Burosumab Sales by Type (2021-2032)
  8. 4.2.3 Global Burosumab Sales Market Share by Type (2021-2032)
  9. 4.3 Global Burosumab Revenue by Type
  10. 4.3.1 Global Burosumab Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Burosumab Revenue by Type (2021-2032)
  12. 4.3.3 Global Burosumab Revenue Market Share by Type (2021-2032)
5 Burosumab Market by Application
  1. 5.1 Burosumab Application Introduction
  2. 5.1.1 Minor Patients Over 1 Year Old
  3. 5.1.2 Adult Patients
  4. 5.2 Global Burosumab Sales by Application
  5. 5.2.1 Global Burosumab Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Burosumab Sales by Application (2021-2032)
  7. 5.2.3 Global Burosumab Sales Market Share by Application (2021-2032)
  8. 5.3 Global Burosumab Revenue by Application
  9. 5.3.1 Global Burosumab Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Burosumab Revenue by Application (2021-2032)
  11. 5.3.3 Global Burosumab Revenue Market Share by Application (2021-2032)
6 Global Burosumab Sales by Region
  1. 6.1 Global Burosumab Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Burosumab Sales by Region (2021-2032)
  3. 6.2.1 Global Burosumab Sales by Region (2021-2026)
  4. 6.2.2 Global Burosumab Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Burosumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Burosumab Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Burosumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Burosumab Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Burosumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Burosumab Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Burosumab Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Burosumab Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Burosumab Revenue by Region
  1. 7.1 Global Burosumab Revenue by Region
  2. 7.1.1 Global Burosumab Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Burosumab Revenue by Region (2021-2026)
  4. 7.1.3 Global Burosumab Revenue by Region (2027-2032)
  5. 7.1.4 Global Burosumab Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Burosumab Revenue (2021-2032)
  8. 7.2.2 North America Burosumab Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Burosumab Revenue (2021-2032)
  11. 7.3.2 Europe Burosumab Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Burosumab Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Burosumab Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Burosumab Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Burosumab Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Ultragenyx
  2. 8.1.1 Ultragenyx Company Information
  3. 8.1.2 Ultragenyx Business Overview
  4. 8.1.3 Ultragenyx Burosumab Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ultragenyx Burosumab Product Portfolio
  6. 8.1.5 Ultragenyx Recent Developments
  7. 8.2 Kyowa Kirin Co.,Ltd.
  8. 8.2.1 Kyowa Kirin Co.,Ltd. Company Information
  9. 8.2.2 Kyowa Kirin Co.,Ltd. Business Overview
  10. 8.2.3 Kyowa Kirin Co.,Ltd. Burosumab Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kyowa Kirin Co.,Ltd. Burosumab Product Portfolio
  12. 8.2.5 Kyowa Kirin Co.,Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Burosumab Value Chain Analysis
  2. 9.1.1 Burosumab Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Burosumab Production Mode & Process
  6. 9.2 Burosumab Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Burosumab Distributors
  9. 9.2.3 Burosumab Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst